|Delayed - 01/15 04:10:00 pm|
Novavax, Merck rise; Regeneron, Anaplan fall
|05/26/2020 | 04:23pm|
The biotechnology company started an early study for a potential coronavirus vaccine.
The auto parts retailer handily beat
The bank terminated a merger deal with
The sporting goods retailer reported surprisingly good first-quarter financial results and a surge in digital sales.
The drug developer is buying back
The software developer gave investors a weak revenue forecast for the current quarter.
The pharmaceutical company is working with Ridgeback Biotherapeutics to develop a treatment for COVID-19.
Bond yields rose as
Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source